Full-Year 2016 results · 2017. 4. 5. · 2016 highlights 2016 has demonstrated the Group’s...
Transcript of Full-Year 2016 results · 2017. 4. 5. · 2016 highlights 2016 has demonstrated the Group’s...
Full-Year 2016 results
5 April 2017
2 Full-Year 2016 results
Contents
1. Introduction
2. FY 2016 financial statements
3. Business review
4. Outlook
5. Q & A
Appendix: Key financial data by business
1. Introduction
2. Consolidated income statement and statement of financial position
3. Business of subsidiaries
4. Strategy and Outlook
Contents
Présentation PowerPoint1. Introduction
Pascal Lebard – Chairman and Chief Executive Officer
3 Full-Year 2016 results
4
2016 highlights
2016 has demonstrated the Group’s ability to delive r solid earnings (excluding the Security division)
Antalis: EBITDA €88 million vs. €94 million in 2015� Earnings held up well in spite of a negative forex impact (mainly sterling) and the sharp decline
in paper volumes � Positive impacts of product mix transformation strategy
� Continued increase in the contribution of Packaging and Visual Communication to Antalis’ margin: up 4 points year on year to 33%
� Continued acquisitions of Packaging and Visual Communication businesses and consolidation of the paper sector (additional full-year sales of €24 million)
Arjowiggins: pro forma EBITDA €28 million vs. €25 m illion in 2015, up 14.0%� Marked turnaround in the operating performances of the Graphic and Creative Papers divisions� Continued decline in results of the Security division � Strengthening of Arjowiggins' financing capacity
� Sale of Arjowiggins Healthcare to Meeschaert Private Equity in partnership with the company's executive management team for an enterprise value of €33 million
� Sale of 15% stake in Arjo Systems and Arjo Solutions (Security Solutions) for an amount of €7 million
Résultats annuels 2016
5
Key pro forma figures for 2016 (excluding ArjowigginsHealthcare which was sold)
Pro forma sales down 7.0% to €2,933 million (down 3 .5% at constant exchange rates)
Pro forma EBITDA stable at €105 million; EBITDA mar gin up 0.2 points to 3.6%
Net loss of €52 million� €72 million in non-recurring expenses, including €14 million in legal costs related to
litigation with BAT, €18 million in asset write-downs (mainly in the Security division), and €40 million in other non-recurring expenses (notably restructuring costs and a quality-related legal dispute)
Net debt stood at €315 million, compared to €235 mi llion at 31 December 2015 � Positive impact of disposals totalling €25 million, offset by costs of financing Antalis
acquisitions (€8 million), disbursements related to restructuring costs (€64 million) and other non-recurring items (€29 million)
� Excluding these items, cash-flow generation was well balanced (negative €5 million)
Résultats annuels 2016
6
Litigation with British American Tobacco (BAT)
Decision of the High Court of Justice of 11 July 20 16� BAT’s claims based on the UK Companies Act 2006 were all dismissed by the Court. BAT’s
claims based on the 1986 Insolvency Act were partially accepted by the Court with regard to the second dividend totalling €135 million, however, the Court did not rule on the amount of any relief to be paid by Sequana pending further hearings
Decision of the High Court of Justice of 10 Februar y 2017� Sequana was ordered to pay BAT an amount of $138.4 million in principal capped at the
amount of the second dividend (€135 million) plus interest (€17 million)� Granted a stay of execution pending the decision of the Court of Appeal� The Court also ordered Sequana to pay part of BAT’s legal costs totalling approximately
€11 million
Sequana has taken legal advice and considers that i t still has solid legal arguments to raise on its own appeal, notably in relation to the application of Article 423 of the Insolvency Act concerning the second dividend.
On the strength of these arguments and the decision handed down in the first judgment, rejecting all of BAT’s claims based on th e Companies Act, no provision was set aside in relation to this matter in the account s for the year ended 31 December 2016
The appeal is unlikely to be heard before 12 to 18 months
Résultats annuels 2016
The preventive procedure ( procédure de sauvegarde ) is continuing and Sequanareiterates its aim of exiting this procedure rapidl y
� Sale of Arjowiggins Security BV to Oberthur Fiduciaire for a gross amount of €30 million planned for May, after the opinion to be issued by the relevant work councils
� The disposal process of the Security division is already under way
� Confirmation of proposed IPO of Antalis, in the form of a distribution of a minority stake of Antalis International shares to its shareholders (between 10% and 30%)
� Preparatory work already in progress� This operation should complete in June
� Bridge loans contracted in November 2016 and March 2017 with Bpifrance Participations and Impala Group, respectively, for an amount of €32 million in exchange for a partial pledge on Antalis International shares along with a strengthening of Arjowiggins’ equity capital� Loans redeemable in cash or in Antalis International shares
7
Implementation of the strategic plan announced on 15 February 2017
Résultats annuels 2016
8
1. Introduction
2. Consolidated income statement and statement of financial position
3. Business of subsidiaries
4. Strategy and Outlook
Contents
Présentation PowerPoint2. FY 2016 financial statements
Xavier Roy-Contancin – Chief Financial Officer
Full-Year 2016 results
9
Consolidated analytical income statement
Net income (loss) attributable - - - (52) (67)to owners
(1) 2016 pro forma data exclude the contribution of Arjowiggins Healthcare which was sold in June 2016.
(2) 2015 pro forma data presented in 2016 exclude the contribution of the Arjowiggins businesses sold in H1 2015 (Security Solutions and Brazilian banknote business) and in H1
2016 (Arjowiggins Healthcare).
(*) Percentage and margin changes are based on figures rounded out to one decimal place.
2016 reported
Non-recurring items - - (72) (76) -Net financial expense - - (36) (41) -Income taxes - - (7) (23) -
Sales 2,933 3,153 - 7.0% 2,975 3,300 - 9.9%
EBITDA 105 106 - 1.1,% 107 126 - 14,9%EBITDA margin (%)(*) 3.6% 3.4% + 0.2 point 3.6% 3.8% - 0.2 points
Recurring operating income 61 57 + 7.5% 63 73 - 13.5%Operating margin (%)(*) 2.1% 1.8% + 0.3 point 2.1 % 2.2% - 0.1 points
2015pro forma (2)
%* 2016 / 2015
reported2016
pro forma (1)
down 3.5% at
constant exchange
rates
(in € millions)2015
reported
%* 2016 pro forma /2015 pro forma
Full-Year 2016 results
10
Breakdown of non-recurring items
Non-recurring items (72)
Restructuring costs (26)Asset write-downs (18)Other non-recurring items (28)
(€ millions) at 31 December 2016 Arjowiggins: €(4) m
Antalis: €(22) m
Incl. €(14)m for BAT
litigation and
€(10)m for quality-related
legal dispute
Full-Year 2016 results
11
Consolidated statement of financial position
(€ millions) 31 Dec. 2016
Goodwill 305 301Property, plant & equipment and intangible assets 183 221Other fixed assets 186 189
Operating WCR 255 259 Other current assets (liabilities) (81) (105)Assets (liabilities) held for sale 14 25
Shareholders' equity 390 468Non-controlling interests - -Provisions 157 187Net debt 315 235
31 Dec. 2015
Full-Year 2016 results
Total assets 862 890
Total equity and liabilities 862 890
12
Breakdown of provisions
(in € millions)
Pension provisions 104 101
Restructuring provisions 21 57
Other risk and contingency provisions 32 29
Total 157 187
31 Dec. 201531 Dec. 2016
Antalis: €4m
Arjowiggins: €17 million
Full-Year 2016 results
13
Change in net debt
(in € millions) 2016
Consolidated net debt – 1 January (235) (311)
EBITDA 107 126Change in WCR of businesses (27) 8CAPEX (38) (49)Asset disposals 11 14
Operating cash flow 53 99
Net finance costs (34) (35)Income tax expense (7) (12)
Restructuring costs & other non-recurring items (93) (93)
Disposals / (acquisitions) 18 135
Financial restructuring programme - (6)Currency impact (6) 1
Other items (11) (13)
Consolidated net debt – 31 December (315) (235)
2015
Full-Year 2016 results
• 2016
Disposals Arjowiggins : 25 M€
Acquisitions Antalis : (8) M€
• 2015
Acquisitions Antalis : (24) M€
Disposals Arjowiggins: 158 M€
• 2016
Antalis : (23) M€
Arjowiggins: (58) M€
Legal costs : (12) M€
• 2015
Antalis : (36) M€
Arjowiggins : (57) M€
14
Consolidated net debt
Consolidated net debt of €315 million vs. €235 million at 31 Dec. 2015
� Antalis: €254 million � Arjowiggins: €49 million
Financial ratios (covenants) at 31 December 2016
� Antalis � Net debt/EBITDA = 2.9 (≤ 3.35)� Recurring operating income/net finance costs = 4.2 (≥ 2.30)
Full-Year 2016 results
15
1. Introduction
2. Consolidated income statement and statement of financial position
3. Business of subsidiaries
4. Strategy and Outlook
Contents
Présentation PowerPoint3. Antalis business review
Hervé Poncin – Chief Operating Officer of Antalis
Full-Year 2016 results
16
Market conditions
A challenging business environment� Uncertain economic climate in the UK and a number of other countries (Spain, Brazil,
Turkey, Russia)� Strong devaluation in the pound sterling with an unfavourable forex impact on Antalis’ sales
and EBITDA � No impact on margin management (both sales and cost base in sterling)
� Major fluctuations in currencies against the euro (South African rand, Chilean peso, etc.)
Contrasting market conditions � In 2016, the paper market registered its biggest decline since those witnessed in 2009
and 2013� The printing paper market contracted by 6%� The drop in volumes was even more marked in the office paper segment, which
contracted by 10%� Packaging and Visual Communication businesses held up well
Consolidation of the European paper distribution ma rket continued apace
Full-Year 2016 results
17
2016 highlights
Continued strategic development in the Packaging an d Visual Communication sectors� Strengthening of central teams� Continued targeted acquisitions policy
� Acquisition of TFM Industrial, a Peruvian distributor of technical packaging solutions for the agri-food, pharmacy and construction sectors (2016 sales of approximately €5 million)
� Acquisition of Norway-based Gregersen, a distributor of equipment and consumables in the visual communication sector (2016 sales of approximately €6 million)
� Organic growth boosted by cross selling
Consolidation of the paper distribution market� Acquisition of Swan Paper distribution business in Ireland (2016 sales of approximately
€13 million)
Steady increase in e-commerce penetration� 26.6% of stock orders are now placed on line, a year-on-year increase of 1.8 points in the sales
penetration rate
Continued adaptation of the supply chain for greate r flexibility, especially in Benelux
Full-Year 2016 results
18
Resilient operating performance
Sales down 6.3% year-on-year (down 2.3% at constant exchange rates)� Negative FX impact for an amount of €109 million (mainly attributable to sterling)� Decrease in paper volumes � Growth in the Packaging and Visual Communication businesses (up 4%) buoyed by the
companies acquired in 2015, which added €51 million to full-year sales� Contributed 33% to Antalis’ margin in 2016 vs. 29% in 2015 (increase of 4 points)
Operating performance held up well� EBITDA came in at €88 million vs. €94 million in 2015; EBITDA margin was stable at 3.6%
� Negative impact of lower volumes, partially offset by an enhanced product mix and lower overheads
� Negative FX impact for an amount of €5 million (mainly attributable to sterling)� Recurring operating income of €64 million vs. €68 million in 2015
Debt was held at €254 million, including acquisitio n financing requirements, thanks to tight control over working capital requirements
Full-Year 2016 results
19
Key income statement items
down 2.3% at
constant exchange
rates
(€ millions)
Sales 2,459 2,625 - 6.3%
EBITDA 88 94 - 5.8%EBITDA margin (%) 3.6% 3.6% -
Recurring operating income 64 68 - 5.3%Operating margin (%) 2.6% 2.6% -
2016 2015Change
2016/2015 €51 million related to
2015 acquisitions
Full-Year 2016 results
Capital employed 449 442ROCE 14.4% 15.4%
EBITDA trends
2015
EBITDA
Forex
impact
Inflation Overheads Bad debts 2016
EBITDA
Margins/Mix/
Volumes
Variable
costs
2015 EBITDA
(excl. FX
impact)
20 Full-Year 2016 results
Acquisitions
(21)
8994
2
12(5)
13 882
0
10
20
30
40
50
60
70
80
90
100
(9)
21
Key cash flow items
(in € millions)
EBITDA 88 94
Change in WCR (15) 41Capex (17) (17)Disposals of fixed assets 3 11
Operating cash flow 59 129
Net debt (254) (232)
2016 2015
Full-Year 2016 results
22
Breakdown of sales and EBITDA
2016 sales by region 2016 EBITDA by region 2016 sales by business
Packaging20%
Main European countries 51%
Rest of the world11%
Germany & Austria13%
Rest of the world9%
France
11%
Rest of Europe 40%
UK& Ireland
27%
Papers71%
Rest of Europe38%
Visual Communication
9%
Full-Year 2016 results
23
1. Introduction
2. Consolidated income statement and statement of financial position
3. Business of subsidiaries
4. Strategy and Outlook
Contents
Présentation PowerPoint3. Arjowiggins business review
Pascal Lebard – Chief Executive Officer
Full-Year 2016 results
24
2016 highlights
Strengthening of Arjowiggins financing capacity � Sale of Arjowiggins Healthcare to Meeschaert Private Equity in partnership with the company's
executive management team for an enterprise value of €33 million� Sale of 15% stake in Arjo Systems and Arjo Solutions (Security Solutions) for an amount of
€7 million
Interesting sales and marketing developments within the divisions � Arjowiggins Graphic
� Development of growth drivers outside the traditional printing and writing market (Teknocard); growth in specialty products (gift cards in the US, shopping bags for major global brands)
� Arjowiggins Creative Papers� New creative paper range for digital printing using dry and liquid toners; development of
specialty applications (non-traditional applications using tracing paper, extension of Priplak’sgeographical reach to the US)
� Arjowiggins Security� Commercial successes underpinned by recent innovations (Wink security thread) but in a
context of fierce competition and deteriorating margins
Full-Year 2016 results
25
Improved operating performance, reflecting the positive impact of the industrial restructuring plan
Key 2016 pro forma figures (excluding Arjowiggins H ealthcare)
Sales down 11.9% to €668 million (down 10.7% at con stant exchange rates)� Decline in printing paper volumes accentuated by the expected drop in volumes of standard
coated paper following the closure of the Wizernes mill � Decline in volumes of banknote paper in a context of overcapacity and downward pressure on
selling prices� Most of the specialty businesses performed well (eco-friendly papers, laminated, tissue paper,
bookbinding, Priplak)
EBITDA up 14% like-for-like to €28 million (from €2 5 million in 2015); EBITDA margin grew by 0.9 points to 4.2% � Positive impact of lower overheads thanks to industrial restructuring� Partially offset by lower volumes of printing paper and banknote paper � Lower prices for raw materials and energy
Recurring operating income at €9 million vs. €2 mil lion in 2015 (on a like-for-like basis)
Excluding the Security division, Arjowiggins’ EBITDA came in at €41 million in 2016
compared to €15 million in 2015 (up €26 million)
Full-Year 2016 results
26
Key income statement items
2016 reported
Sales 668 758 - 11.9% 710 905 - 21.6%
EBITDA 28 25 + 14.0% 30 45 - 31.8%EBITDA margin (%) 4.2% 3.3% + 0.9 points 4.3% 4.9% - 0.6 points
Recurring operating income 9 2 NA 11 18 - 37.4% Operating margin (%) 1.4% 0.3% + 1.1 points 1.6% 2.0% - 0.4 points
2015pro forma (2)
Change 2016/2015 (reported)
2016pro forma (1)
down 10.7% at
constant exchange
rates
(in € millions)2015
reported
Change 2016 pro forma /2015
pro forma
(1) 2016 pro forma data exclude the contribution of Arjowiggins Healthcare which was sold in June 2016.
(2) 2015 pro forma data presented in 2016 exclude the contribution of the Arjowiggins businesses sold in H1 2015 (Security Solutions and Brazilian banknote
business) and in H1 2016 (Arjowiggins Healthcare).
Full-Year 2016 results
Capital employed 140 194ROCE 8.1% 9.4%
2015
EBITDA
Change
in 2015
reporting
scope
Prix & Mix Overheads Overheads
Wizernes &
Charavines
2016 EBITDA
from
continued
operations
Security 2015
EBITDA (excl.
Security)
2015 EBITDA (from continued
operations)
FX
gains/losses
EBITDA trends
27 Full-Year 2016 results
Healthcare Volumes Pulp, RMs
& energy
Graphic & Creative Papers
20 41
(2)
2
(14)
25
45
18
(10)
(2)(10)
0
10
20
30
40
50
(6)
15
28
Key cash flow items
(in € millions)
EBITDA 30 45
Change in WCR (15) (31)Capex (21) (32)Disposals of fixed assets 9 3
Operating cash-flow 3 (15)
Net debt (49) (1)
2016 2015
Full-Year 2016 results
29
Pro forma results by division
� Drop in volumes of standard coated paper due to closure of Wizernes mill
� Resilient performance in eco-friendly papers and laminated and tissue businesses
� Lower overheads arising from closure of Wizernes mill
� Positive impact of lower raw material prices
329
369
2016
17
(1)
20162015
2015
Graphic
Pro forma sales (€ millions) Pro forma EBITDA (€ milli ons)
216228
2016
24
16
2016 20152015
Creative papers� Decline in volumes of fine papers,
accentuated by � flooding at the Stoneywood mill in
early January and production difficulties linked to the transfer of production from Charavines
� Lower overheads related to industrial restructuring
� Partially offset by the negative impact of sub-contracting costs related to inventory rebuilding
Pro forma EBITDA (€ millions)
- 5.3%
- 10.8%
NA
Full-Year 2016 results
NA
Pro forma sales (€ millions)
30
Pro forma results by division
� Decline in volumes of banknote paper in a context of overcapacity and downward pressure on selling prices
� Accentuated by- a quality issue that slowed down
and disrupted production and productivity
- last-minute cancellation of a major order which did not make it possible to offset these volumes
Security
(13)
2016
2015
123
161
2016 2015
Pro forma sales (€ millions) Pro forma EBITDA (€ milli ons)
10- 24.0%
NA
Full-Year 2016 results
31
Breakdown of 2016 sales and EBITDA
Creative Papers30%
Security 18%
Graphic52%
Rest of the world7%
US12%
France20%
UK
9%
Europe (excl. France & UK)
37%
Asia15%
Sales by regionSales by division EBITDA by division (1)
Graphic45%
Creative Papers55%
Coated
14%
Green
46%
Specality
40%
(1) excludes €13 million in negative
EBITDA from the Security division
Full-Year 2016 results
32
1. Introduction
2. Consolidated income statement and statement of financial position
3. Business of subsidiaries
4. Strategy and Outlook
Contents
Présentation PowerPoint4. Outlook
Pascal Lebard – Chairman and Chief Executive Officer
Full-Year 2016 results
Contrasting market conditions� Continuing decline in volumes of printing paper � Good momentum in Antalis’ Packaging and Visual Communication businesses and in
Arjowiggins’ specialty businesses� Higher prices for raw materials and chemicals (pulp, latex) and energy (gas)
Antalis� Positive impacts of lower overheads (continued adaptation of the supply chain for greater
flexibility)� Enhanced margin as a result of product mix transformation strategy and the positive impact of
acquisitions completed in 2016� Continued increase in the overall contribution of Packaging and Visual Communication to
Antalis’ margin
Arjowiggins� Continued positive impacts of the Graphic and Creative papers divisions’ industrial
restructuring, partially offset by losses in the Security division� Turnaround of the French banknote business using proceeds from the sale of Arjowiggins
Security BV should the disposal process be unsuccessful
The planned IPO for Antalis will unlock its value. It will also provide Sequana with the additional financial resources needed to run its op erations and meet its obligations .
33
Outlook for 2017
Résultats annuels 2016
34
1. Introduction
2. Consolidated income statement and statement of financial position
3. Business of subsidiaries
4. Strategy and Outlook
Contents
Présentation PowerPoint5. Q & A
Pascal Lebard – Chairman and Chief Executive Officer of Sequana
Xavier Roy-Contancin – Chief Financial Officer
Hervé Poncin – Executive Vice-President of Sequana, Chief Operating Officer of Antalis
Full-Year 2016 results
35
1. Introduction
2. Consolidated income statement and statement of financial position
3. Business of subsidiaries
4. Strategy and Outlook
Contents
Présentation PowerPoint www.sequana.com
� +33 1 58 04 22 80
Full-Year 2016 results
36
1. Introduction
2. Consolidated income statement and statement of financial position
3. Business of subsidiaries
4. Strategy and Outlook
Contents
Présentation PowerPoint
Appendix - Key financial data by business
Full-Year 2016 results
37
Results by business
(in € millions)
Sales – Antalis 2,459 2,625 - 6.3%
Sales – Arjowiggins 668 758 - 11.9%
Eliminations & holding company (194) (230) -
Consolidated net sales 2,933 3,153 - 7.0%
EBITDA – Antalis 88 94 - 5.8%
EBITDA – Arjowiggins 28 25 + 14.0%
EBITDA – Eliminations & holding company (11) (13) -
Consolidated EBITDA 105 106 - 1.1%
2016
pro forma (1)
Change 2016 pro forma/2015 pro forma
Recurring operating income – Antalis 64 68 - 5.3%
Recurring operating income – Arjowiggins 9 2 NA
Recurring op. loss – Eliminations & holding co. (12) (13) - 4.7%
Consolidated recurring operating income 61 57 + 7.5%137
2015
pro forma (2)
(1) 2016 pro forma data exclude the contribution of Arjowiggins Healthcare which was sold in June 2016.
(2) 2015 pro forma data presented in 2016 exclude the contribution of the Arjowiggins businesses sold in H1 2015 (Security Solutions and Brazilian
banknote business) and in H1 2016 (Arjowiggins Healthcare).
Full-Year 2016 results
38
Antalis
(in € millions)
Sales – Europe 2,232 2,384 - 6.4%
Sales – Rest of the World 227 241 - 5.7%
Sales – Antalis 2,459 2,625 - 6.3%
EBITDA Europe 78 85 - 7.6%
EBITDA – Rest of the World 10 9 + 11.5%
EBITDA – Antalis 88 94 - 5.8%
2016
Recurring operating income – Europe 58 63 - 6.7%
Recurring op. income – Rest of the World 6 5 + 12.4%
Recurring operating income – Antalis 64 68 - 5.3 %
2015Change
2016 /2015
Europe
2016 sales by region
Rest of the world
2016 sales by region
Asia24%
South Africa32%
Latin America
44%
Rest of Europe44 %
Germany & Austria
14%
UK& Ireland
30%
France
12%
Full-Year 2016 results
39
Results by division
(in € millions)
Sales - Graphic 329 369 - 10.8%Sales - Creative Papers 216 228 - 5.3%Sales - Security 123 161 - 24.0%
Sales 668 758 - 11.9%
EBITDA Graphic 17 (1) NAEBITDA Creative Papers 24 16 + 49.0%EBITDA Security (13) 10 NA
EBITDA 28 25 + 14.0%
2016pro forma (1)
Recurring op. income/(loss) - Graphic 11 (9) NAR O I - Creative Papers 20 12 NARecurring op. inc (loss) - Security (22) (1) NA
Recurring operating income 9 2 NA
2015pro forma (2)
% change2016 pro forma/ 2015 pro forma
(1) 2016 pro forma data exclude the contribution of Arjowiggins Healthcare which was sold in June 2016.
(2) 2015 pro forma data presented in 2016 exclude the contribution of the Arjowiggins businesses sold in H1 2015 (Security Solutions and
Brazilian banknote business) and in H1 2016 (Arjowiggins Healthcare).
Full-Year 2016 results
1. Introduction
2. Consolidated income statement and statement of financial position
3. Business of subsidiaries
4. Strategy and Outlook
Contents
Présentation PowerPoint www.sequana.com
� +33 1 58 04 22 80